Pharmacologic management of temporomandibular joint disorders and chronic head and neck pain.
暂无分享,去创建一个
[1] Martin H. Teicher,et al. Dr. Teicher and Associates Reply , 1990 .
[2] E. N. Gale,et al. A prevalence study of the clinical signs associated with mandibular dysfunction. , 1983, Journal of the American Dental Association.
[3] W. Beaver. Analgesic Development: A Brief History and Perspective , 1980, Journal of clinical pharmacology.
[4] R. Brooke. Atypical odontalgia. A report of twenty-two cases. , 1980, Oral surgery, oral medicine, and oral pathology.
[5] B. Rodda,et al. Interactions of aspirin with nonsteroidal antiinflammatory drugs in man. , 1973, Arthritis and rheumatism.
[6] L. P. Gangarosa. Pharmacology of agents used to treat temporomandibular joint (TMJ) problems. , 1973, The Journal of prosthetic dentistry.
[7] G. Levy,et al. Salicylate accumulation kinetics in man. , 1972, The New England journal of medicine.
[8] Bourne Hr. The placebo--a poorly understood and neglected therapeutic agent. , 1971 .
[9] H. Paulus,et al. Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. , 1971, Arthritis and rheumatism.
[10] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1976 .
[11] B. Crue. The Neurophysiology and Taxonomy of Pain , 1983 .